Intentional hastening of death through medication: a case series analysis of Victorian deaths prior to the Voluntary Assisted Dying Act 2017.

assisted dying end-of-life decision-making health law medical law palliative care treatment decisions

Journal

Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952

Informations de publication

Date de publication:
Oct 2021
Historique:
revised: 13 06 2021
received: 13 12 2020
accepted: 14 06 2021
pubmed: 18 6 2021
medline: 26 10 2021
entrez: 17 6 2021
Statut: ppublish

Résumé

Voluntary assisted dying is lawful in Victoria in limited circumstances and commences in Western Australia in mid-2021. There is evidence that in rare cases, unlawful assisted dying practices occur in Australia. To determine whether assisted dying practices occurred in Victoria in the 12 months prior to the commencement of the Voluntary Assisted Dying Act 2017 (Vic) ('VAD Act'), and to examine features of any identified cases. Exploratory case series of adult patients in Victoria who died between May 2018 and 18 June 2019 as a result of medication administered with the primary intention of hastening death. Cases were identified from a self-administered survey about medical end-of-life decisions for adult patients, completed by Victorian specialists treating adults at the end of life. We examined reported use of medication with the primary intention of hastening the patient's death; characteristics of assisted dying cases, including doctors' classification of such practices. Nine cases met the inclusion criteria. Death did not occur immediately after providing medication with the intention of hastening death. In eight cases, it was framed as palliative or terminal sedation and/or continuous deep sedation. Most doctors used language that distanced their practices from assisted dying. Unlawful assisted dying practices seem to have occurred in a small number of deaths in Victoria prior to commencement of the VAD Act. These practices typically occurred within the context of palliative or terminal sedation and may be difficult to distinguish from lawful palliative care practice. Some survey responses possibly reflect ambiguity in doctors' intentions when providing medication.

Sections du résumé

BACKGROUND BACKGROUND
Voluntary assisted dying is lawful in Victoria in limited circumstances and commences in Western Australia in mid-2021. There is evidence that in rare cases, unlawful assisted dying practices occur in Australia.
AIMS OBJECTIVE
To determine whether assisted dying practices occurred in Victoria in the 12 months prior to the commencement of the Voluntary Assisted Dying Act 2017 (Vic) ('VAD Act'), and to examine features of any identified cases.
METHODS METHODS
Exploratory case series of adult patients in Victoria who died between May 2018 and 18 June 2019 as a result of medication administered with the primary intention of hastening death. Cases were identified from a self-administered survey about medical end-of-life decisions for adult patients, completed by Victorian specialists treating adults at the end of life. We examined reported use of medication with the primary intention of hastening the patient's death; characteristics of assisted dying cases, including doctors' classification of such practices.
RESULTS RESULTS
Nine cases met the inclusion criteria. Death did not occur immediately after providing medication with the intention of hastening death. In eight cases, it was framed as palliative or terminal sedation and/or continuous deep sedation. Most doctors used language that distanced their practices from assisted dying.
CONCLUSIONS CONCLUSIONS
Unlawful assisted dying practices seem to have occurred in a small number of deaths in Victoria prior to commencement of the VAD Act. These practices typically occurred within the context of palliative or terminal sedation and may be difficult to distinguish from lawful palliative care practice. Some survey responses possibly reflect ambiguity in doctors' intentions when providing medication.

Identifiants

pubmed: 34139049
doi: 10.1111/imj.15435
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1650-1656

Subventions

Organisme : Study funded by the National Health and Medical Research Council (NHMRC), through the Centre for Research Excellence in End-of-Life Care, based at the Queensland University of Technology

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 Royal Australasian College of Physicians.

Références

Magnusson RS, Ballis PH. Angels of Death: Exploring the Euthanasia Underground. Melbourne: Melbourne University Press; 2002.
Baume P, O'Malley E. Euthanasia: attitudes and practices of medical practitioners. Med J Aust 1994; 161: 137-44.
Douglas CD, Kerridge IH, Rainbird KJ, McPhee JR, Hancock L, Spigelman AD. The intention to hasten death: a survey of attitudes and practices of surgeons in Australia. Med J Aust 2001; 175: 511-15.
Hassan R. Euthanasia and the medical profession: an Australian study. Aust J Soc Issues 1996; 31: 239-52.
Kuhse H, Singer P. Doctors' practices and attitudes regarding voluntary euthanasia. Med J Aust 1988; 148: 623-7.
Kuhse H, Singer P, Rickard M, Baume P, Clark M. End-of-life decisions in Australian medical practice. Med J Aust 1997; 166: 191-6.
Neil DA, Coady C, Thompson J, Kuhse H. End-of-life decisions in medical practice: a survey of doctors in Victoria (Australia). J Med Ethics 2007; 33: 721-5.
van der Maas P, van der Wal G, Haverkate I, de Graaff CL, Kester JG, Onwuteaka-Philipsen BD et al. Euthanasia, physician-assisted suicide, and other medical practices involving the end of life in the Netherlands, 1990-1995. N Engl J Med 1996; 335: 1699-705.
Riou F, Aubry R, Pontone S, Pennec S. When physicians report having used medical drugs to deliberately end a patient's life: findings of the “End-of-Life in France” survey. J Pain Symptom Manage 2015; 50: 208-15.
Malpas P, Mitchell K, Koschwanez H. End-of-life medical decision making in general practice in New Zealand-13 years on. N Z Med J 2015; 128: 27-9.
Mitchell K, Owens G. End of life decision-making by New Zealand general practitioners: a national survey. N Z Med J 2004; 117: U934.
Bilsen J, Vander Stichele R, Broeckaert B, Mortier F, Deliens L. Changes in medical end-of-life practices during the legalization process of euthanasia in Belgium. Soc Sci Med 2007; 65: 803-8.
Deliens L, Mortier F, Bilsen J, Cosyns M, Stichele RV, Vanoverloop J et al. End-of-life decisions in medical practice in Flanders, Belgium: a nationwide survey. Lancet 2000; 356: 1806-11.
van der Heide A, Deliens L, Faisst K, Nilstun T, Norup M, Paci E et al. End-of-life decision-making in six European countries: descriptive study. Lancet 2003; 362: 345-50.
Schildmann J, Hoetzel J, Mueller-Busch C, Vollmann J. End-of-life practices in palliative care: a cross sectional survey of physician members of the German Society for Palliative Medicine. Palliat Med 2010; 24: 820-7.
Pennec S, Monnier A, Pontone S, Aubry R. End-of-life medical decisions in France. Popul Soc 2012; 494: 1-4.
Seale C. National survey of end-of-life decisions made by UK medical practitioners. Palliat Med 2006; 20: 3-10.
Seale C. End-of-life decisions in the UK involving medical practitioners. Palliat Med 2009; 23: 198-204.
Marcoux I, Boivin A, Mesana L, Graham ID, Hebert P. Medical end-of-life practices among Canadian physicians: a pilot study. CMAJ Open 2016; 4: E222-9.
Willmott L, White B, Feeney R, Chambaere K, Yates P, Mitchell G et al. Collecting data on end-of-life decision-making: questionnaire translation, adaptation and validity assessment. Prog Palliat Care 2021: 1-11. https://doi.org/10.1080/09699260.2021.1922795.
Rezigalla AA. Observational study designs: synopsis for selecting an appropriate study design. Cureus 2020; 12: e6692.
Douglas C, Kerridge I, Ankeny R. Managing intentions: the end-of-life administration of analgesics and sedatives, and the possibility of slow euthanasia. Bioethics 2008; 22: 388-96.
Cherny NI, Radbruch L, Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 2009; 23: 581-93.
Schildmann E, Pörnbacher S, Kalies H, Bausewein C. ‘Palliative sedation’? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit. Palliat Med 2018; 32: 1189-97.
Sterckx S, Raus K. The practice of continuous sedation at the end of life in Belgium: how does it compare to UK practice, and is it being used as a form of euthanasia? In: Jones DA, Gastmans C and MacKellar C, eds Euthanasia and Assisted Suicide: Lessons from Belgium. Cambridge: Cambridge University Press; 2017; 86-100.
Australian and New Zealand Society of Palliative Medicine (ANZSPM) Palliative sedation therapy guidance document. Canberra: ANZSPM; 2017 [cited 2021 Mar 23]. Available from URL: http://test.anzspm.org.au/c/anzspm?a=sendfile&ft=p&fid=1618280817&sid=
Akashi M, Yano E, Aruga E. Under-diagnosis of pain by primary physicians and late referral to a palliative care team. BMC Palliat Care 2012; 11: 1-9.
Dierickx S, Cohen J, Vander Stichele R, Deliens L, Chambaere K. Drugs used for euthanasia: a repeated population-based mortality follow-back study in Flanders, Belgium, 1998-2013. J Pain Symptom Manage 2018; 56: 551-9.

Auteurs

Lindy Willmott (L)

Australian Centre for Health Law Research, Queensland University of Technology, Brisbane, Queensland, Australia.

Ben White (B)

Australian Centre for Health Law Research, Queensland University of Technology, Brisbane, Queensland, Australia.

Rachel Feeney (R)

Australian Centre for Health Law Research, Queensland University of Technology, Brisbane, Queensland, Australia.

Kenneth Chambaere (K)

Sociology and Ethics of the End of Life, End-of-Life Care Research Group, Vrije Universiteit Brussel and Ghent University, Brussels, Belgium.

Patsy Yates (P)

Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.

Geoffrey Mitchell (G)

Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH